Related Experiment Video
Updated: Aug 17, 2025
08:01
Generation and Expansion of Primary, Malignant Pleural Mesothelioma Tumor Lines
Published on: April 21, 2022
2.0K
Malignant peritoneal mesothelioma-a diagnostic challenge.
Saad Abdul Razzak1, Faisal Awan2, Salman Ahmed1
1General Surgery Department, St. Luke's General Hospital, Kilkenny, Ireland.
Journal of Surgical Case Reports
|December 15, 2022
Summary
Malignant peritoneal mesothelioma, a rare cancer, presents subtly. Diagnosis requires histological and BAP1 gene analysis, guiding palliative treatment when surgery isn't an option.
Area of Science:
- Oncology
- Pathology
- Genetics
Background:
- Malignant peritoneal mesothelioma is a rare malignancy with a poor prognosis.
- It often presents with non-specific symptoms, complicating early diagnosis.
Observation:
- A 60-year-old male presented with shortness of breath, lethargy, weight loss, abdominal pain, and night sweats.
- A 2-month diagnostic workup was required to identify the primary cancer.
Findings:
- Diagnosis was confirmed via immunohistochemical analysis revealing BAP1 gene loss.
- The patient was unsuitable for surgery and received palliative carboplatin and pemetrexed chemotherapy.
Implications:
- Histological diagnosis is crucial for peritoneal diseases to differentiate from metastases.
- Immunohistochemistry and genetic profiling are vital for accurate diagnosis and treatment planning in rare cancers.
